Search for: "Medimmune, Inc."
Results 161 - 180
of 248
Sorted by Relevance
|
Sort by Date
21 Feb 2012, 9:42 am
Wellman, Inc. [read post]
2 Oct 2011, 10:29 am
TESSERA:In Arris Group Inc. v. [read post]
14 Sep 2017, 1:30 pm
” Citing to MedImmune v. [read post]
9 Jul 2008, 2:40 am
The panel held that MedImmune, Inc. v. [read post]
28 Apr 2020, 11:46 pm
by Olivia Henry and Nicholas Michelmore On 20 April 2020, Arnold LJ (sitting as a High Court Judge) gave judgment in the case between FibroGen Inc and Astellas Pharma Inc (together the “Claimants”), and Akebia Therapeutics Inc and Otsuka Pharmaceutical Company Limited (together the “Defendants”) which concerned six patents owned by FibroGen and exclusively licensed to Astellas (the “Patents”). [read post]
27 Apr 2011, 1:47 pm
Accession, Inc. [read post]
2 Mar 2013, 1:17 pm
USA, Inc. v. [read post]
11 Mar 2015, 9:40 am
MercExchange, L.L.C., 547 U.S. 388 (2006) (injunctive relief) MedImmune, Inc. v. [read post]
31 Jul 2011, 9:28 pm
" MedImmune, Inc. v. [read post]
8 Dec 2014, 12:42 pm
” MedImmune, Inc. [read post]
28 Mar 2009, 4:40 pm
., Craig Allen Nard, The Law of Patents 34 (2008) (asserting PTO grants patents on 39% of applications); Brief of the Boston Patent Law Ass'n as Amicus Curiae in Support of Genentech, Inc., on the Merits at 5, Medimmune, Inc. v. [read post]
6 Apr 2014, 7:42 pm
” MedImmune, Inc. v. [read post]
19 Dec 2011, 1:38 pm
Prometheus Laboratories, Inc., (reported in our December 7th post) the American Civil Liberties Union Foundation (“ACLU”) and the Public Patent Foundation petitioned the U.S. [read post]
8 Mar 2011, 6:33 pm
Teleflex Inc., 550 U.S. 398 (2007) (eliminating technical hurdles for proving an invention obvious and instead applying a "common sense" analysis for assessing patentability); MedImmune, Inc. v. [read post]
15 Nov 2011, 2:00 am
” , or phrases a new meaning, Medimmune, Inc. v. [read post]
25 Jan 2010, 5:00 am
See Basic, Inc. v. [read post]
13 May 2007, 10:51 pm
Also worth a good look is the warning by Adrian Punderson (Ashworth Inc) concerning the threats from within that can lead to counterfeiting when legitimate manufacturers don't keep a keen eye on their own operations.Full contents of issue 6 here [read post]
21 Apr 2008, 2:52 pm
Forest Labs., Inc. after the jump. [read post]
29 Dec 2009, 9:09 pm
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
29 Dec 2009, 9:09 pm
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
